Matinas BioPharma | Investor Presentation Deck | 29 slides · page 16 of 29
The slide outlines a non-inferiority trial design comparing oral MAT2203 to IV LAMB/SoC.
Pitch deck · appendix_methodology · plan_implementation · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
diagram 1/1 list 3/3 paragraph 2/2 source-note 1/1 title 1/1
Components 8
process bullet bullet bullet paragraph paragraph source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.